Skip to Main Content

Top of the morning to you, and a fine one, it is. Yes, we are feeling cheery today, thanks to sunny skies and moderating temperatures enveloping the Pharmalot campus. Moreover, the view from our window offers us a look at a cornucopia of fluttering leaves and colorful trees. A nice way to start the day. So to celebrate, we are brewing cups of stimulation — we are stuck on maple pecan, for those who track this sort of thing — and invite you to join us. While you consider what to do, here are some tidbits. Hope your day is successful and, of course, do keep in touch.

A new report examining the first decade of study results reported on finds there has been slow progress among drug makers and academic research centers in reporting the results of human studies, but the quality of the data may still pose a larger problem, STAT says. When the database was expanded through federal law in 2008 to accommodate clinical trial results, an average of two trials per week posted results, even though 79 trials were completed every week. In 2018, 68 trials with results were posted out of 135 completed trials.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!